Estudios originales
Published on 17 de abril de 2024 | http://doi.org/10.5867/medwave.2024.03.2758
Metabolic control in type 2 diabetic patients treated with empagliflozin: A case series
Glycosylated hemoglobin A1c less than 7.5%.

Source: Prepared by the authors of this study.